Page 11234..1020..»


Category Archives: Obesity Medical Treatment

Detox Products Market Obesity and Alcohol Addiction to Drive Growth in the Market – TMR Research Blog


Posted: March 27, 2020 at 3:50 am

Increasing awareness regarding health, couple with an increase in disposable income, is set to drive the global detox products market on to a high growth trajectory. It is significant to make note here of the fact that health awareness is growing and the growth is manifesting itself in people hitting the gyms and exercise studios more often than before, and taking to detoxification activities on a war scale Continue reading

Posted in Obesity Medical Treatment | Comments Off on Detox Products Market Obesity and Alcohol Addiction to Drive Growth in the Market – TMR Research Blog

Leptin Levels are Associated with Subclinical Cardiac Dysfunction in O | DMSO – Dove Medical Press


Posted: March 27, 2020 at 3:50 am

Thamonwan Imerbtham,1 Piyanuch Thitiwuthikiat,1 Jirapas Jongjitwimol,2 Teonchit Nuamchit,1 Teerapat Yingchoncharoen,3 Duangduan Siriwittayawan1 1Department of Cardio-Thoracic Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand; 2Department of Medical Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand; 3Department of Internal Medicine, Faculty of Medicine, Mahidol University, Bangkok, Thailand Correspondence: Duangduan SiriwittayawanDepartment of Cardio-Thoracic Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, ThailandTel +66 55 966 417Fax +66 55 966 234Email duangduans@nu.ac.th Purpose: The purposes of this study were to use speckle tracking echocardiography to confirm the influence of obesity on cardiac functions and to assess their relationships with leptin and uric acid levels in obese adolescents.Methods: Eighty-one participants aged 16 19 years were recruited and classified as either non-obese (n = 30) or obese (n = 51). Continue reading

Posted in Obesity Medical Treatment | Comments Off on Leptin Levels are Associated with Subclinical Cardiac Dysfunction in O | DMSO – Dove Medical Press

Wisconsin organization seeks to combat increasing obesity rate – The Badger Herald


Posted: March 27, 2020 at 3:50 am

According to the United States CIA, the U.S. has the 12th highest obesity rate in the world as of 2016, with about 32.6% of the population considered obese. While this is an issue across the entire country, the areas most affected by obesity are the South (33.6%) and the Midwest (33.1%), based on research done by the Center for Disease Control and Prevention. Continue reading

Posted in Obesity Medical Treatment | Comments Off on Wisconsin organization seeks to combat increasing obesity rate – The Badger Herald

COVID-19 Warning: Being Overweight Or Obese Ups Your Risk Of Dying From Coronavirus – International Business Times


Posted: March 26, 2020 at 3:44 am

The COVID-19 is a relatively new disease and it might take time to gather adequate information. But, a recent NHS survey suggested that over 60% of COVID-19 patients under intensive care are either overweight or morbidly obese Continue reading

Posted in Obesity Medical Treatment | Comments Off on COVID-19 Warning: Being Overweight Or Obese Ups Your Risk Of Dying From Coronavirus – International Business Times

Obesity and stigma: A woman’s journey to a healthy lifestyle – The New Times


Posted: March 26, 2020 at 3:44 am

It all started when she had just given birth to her second child. Her weight began to escalate and as a result, she began experiencing chronic back problems. Continue reading

Posted in Obesity Medical Treatment | Comments Off on Obesity and stigma: A woman’s journey to a healthy lifestyle – The New Times

Kallyope Gains $112M to Move Gut-Brain Axis Programs to the Clinic – Xconomy


Posted: March 26, 2020 at 3:44 am

XconomyNew York Kallyope, one of New Yorks best funded biotechs, has secured more than $100 million to move two of its programs into the clinicincluding its most advanced, an experimental drug designed to treat obesity. The company was founded in 2015 with $44 million to leverage new learnings about the gut-brain axispings of communication between our guts and our central nervous systemto make drugs for a range of diseases. Since then the company has raised $199 million more across two subsequent rounds of funding, including a $112 million Series C financing announced Wednesday, and advanced two programs to the cusp of human testing Continue reading

Posted in Obesity Medical Treatment | Comments Off on Kallyope Gains $112M to Move Gut-Brain Axis Programs to the Clinic – Xconomy

America’s Obesity Problem, By the Numbers – Oddee


Posted: March 26, 2020 at 3:44 am

It has been known for a while that the United States has a serious obesity problem. An estimated 160 million American adults some 60% of women, and nearly 75% of men are overweight at minimum Continue reading

Posted in Obesity Medical Treatment | Comments Off on America’s Obesity Problem, By the Numbers – Oddee

OBESITY MANAGEMENT MARKET TRENDS, STRONG APPLICATION SCOPE, KEY PLAYERS, GROWTH OVERVIEW AND FORECAST BY 2027 – Packaging News 24


Posted: March 26, 2020 at 3:44 am

The Insight Partners delivers well-researched industry-wide information on the Obesity Management market. Continue reading

Posted in Obesity Medical Treatment | Comments Off on OBESITY MANAGEMENT MARKET TRENDS, STRONG APPLICATION SCOPE, KEY PLAYERS, GROWTH OVERVIEW AND FORECAST BY 2027 – Packaging News 24

Coronavirus and obesity: industry urged to act post-crisis – FoodNavigator.com


Posted: March 25, 2020 at 12:44 am

The report from the London-based Intensive Care National Audit and Research Centre looked at the data of 196 patients admitted to critical care with confirmed COVID-19 up to 19 March 2020. Of these, 57 were female and 139 were male, with an average age of 64. Only 23 of the patients previously required some assistance with daily activities prior to the onset of acute illness Continue reading

Posted in Obesity Medical Treatment | Comments Off on Coronavirus and obesity: industry urged to act post-crisis – FoodNavigator.com

Microbial signatures identified in the liver, adipose tissue and blood of people with obesity and diabetes – Gut Microbiota for Health


Posted: March 25, 2020 at 12:44 am

When seeking a causative factor for the onset of insulin resistance and low-grade inflammation that usually accompanies obesity and diabetes, in the past scientists have turned to bacterial lipopolysaccharide (LPS) as a triggering factor. However, the causal role of gut microbiota in obesity and type 2 diabetes (T2D) remains elusive. Continue reading

Posted in Obesity Medical Treatment | Comments Off on Microbial signatures identified in the liver, adipose tissue and blood of people with obesity and diabetes – Gut Microbiota for Health

Page 11234..1020..»